IVF Form 4: Steven Shum Receives 42,000 Options, Expiring 08/26/2035

Rhea-AI Filing Summary

Steven Shum, listed as Chief Executive Officer and a Director of INVO Fertility, Inc. (IVF), filed a Form 4 reporting an equity compensation transaction dated 08/26/2025. The filing shows a grant of a stock option with an exercise price of $1.01 covering 42,000 underlying shares, exercisable through 08/26/2035. The option vests in four equal installments beginning on the first day of the calendar quarter following 08/26/2025 and on the first day of each calendar quarter thereafter until fully vested. Following the reported transaction, the filing lists beneficial ownership of 42,451 shares of common stock held directly.

Positive

• 42,000 stock options granted with an explicit vesting schedule
• Option grant has a clear expiration date of 08/26/2035
• Filing discloses 42,451 shares beneficially owned following the transaction

Negative

• Grant increases potential share count by 42,000 underlying shares
• Vesting begins after the grant date, so not immediately exercisable

Insights

Corporate Governance Specialist

Insider option grant with multi‑quarter vesting and a 10‑year term.

The Form 4 confirms a 42,000 stock option award to Steven Shum dated 08/26/2025 with an exercise price of $1.01 and an expiration of 08/26/2035. The disclosed vesting schedule begins the first calendar quarter after the grant and vests in four equal installments, which is a time‑based retention structure.

The filing also shows 42,451 shares beneficially owned following the transaction, reported as direct ownership. These are explicit, reportable changes under Section 16 and are relevant to governance and disclosure oversight.

Compensation Analyst

Grant details indicate the option is low‑strike and long‑dated.

The option's $1.01 strike and 10‑year lifespan (expiration 08/26/2035) are stated verbatim in the filing and define the contract terms available to the reporting person. Vesting in four equal quarterly installments beginning after 08/26/2025 is a factual schedule disclosed in the explanation.

No cash amounts paid or exercised are disclosed in the form; the document only reports the grant and resulting beneficial ownership figures.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Shum Steve

(Last) (First) (Middle)

C/O INVO FERTILITY, INC.

5582 BROADCAST COURT

(Street)

SARASOTA FL 34240

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
INVO Fertility, Inc. [ IVF ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/26/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								674	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$1.01	08/26/2025		A		42,000		(1)	08/26/2035	Common Stock	42,000	$0	42,451	D

Explanation of Responses:

1. The option vests in four equal installments beginning on the first day of the calendar quarter following August 26, 2025 and on the first day of each calendar quarter thereafter until fully vested.

	/s/ Steven Shum	10/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Steven Shum (IVF) report on Form 4?

He reported a grant of a stock option dated 08/26/2025 for 42,000 underlying shares with an exercise price of $1.01.

When does the option granted to IVF's CEO vest and expire?

The option vests in four equal installments starting the first day of the calendar quarter following 08/26/2025 and expires on 08/26/2035.

How many shares does Steven Shum beneficially own after the reported transaction?

The Form 4 lists 42,451 shares of common stock as beneficially owned following the reported transaction.

What is the exercise price of the option on the Form 4 for IVF?

The exercise (conversion) price disclosed is $1.01 per share.

Was the Form 4 filed individually or jointly?

The filing indicates it was filed by one reporting person (individual filing).